Health
Oxford-AstraZeneca vaccine effective against B.1.1.7 SARS-CoV-2 variant – News-Medical.Net
Published in The Lancet, the study explores if the Oxford-AstraZeneca vaccine works well in protecting against the B.1.1.7 variant, otherwise known as the U.K….
The coronavirus disease (COVID-19) pandemic continues to spread globally, with new variants emerging. One of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants is the B.1.1.7 or U.K. variant. It is still unclear if the developed vaccines can protect against new emerging variants.
Now, researchers at the COVID-19 Genomics United Kingdom Consortium, the AMPHEUS Project, and the Oxford COVID-19 Vaccine Trial Group released the results of their exploratory analysis of a randomized…
-
Noosa News23 hours agoInside the illegal tobacco trade —secret rooms, fire bombings and bags full of cash
-
Business21 hours agoThese ASX 200 shares could rise 15% to 20%
-
Business21 hours agoEvery ASX 200 sector closed in the red last week. Here’s why
-
Noosa News23 hours agoGT3 driver Renee Gracie on sexism in motorsport and how OnlyFans turned her career around